Cameron Santoro is an associate editor for The American Journal of Managed Care® (AJMC®), AJMC.com, and The Center for Biosimilars®.
Dr Jenny Craven Evaluates Cost of New Therapies, Ways to Gain Stakeholder Support
Jenny Craven, PharmD, BCPS, of the University of California Davis Health reviews the finances associated with Emerging Therapy Committee and examines the benefits of the adoption process of new therapies.
Kimberly Westrich Addresses Patient-Centricity Strategies, Benefits in Health Care
Kimberly Westrich, MA, of the National Pharmaceutical Council, addresses the benefits of incorporating patient-centricity throughout the health care system to foster more accurate and better quality of care.
Dr Sarah Bajorek Highlights Integration, Evaluation Strategies for Gene Therapy Implementation
Sarah Bajorek, PharmD, MBA, BCACP, University of California, Davis Health, discusses notable gene therapies emerging into the market and strategies to proactively engage with a wide range of stakeholders during the integration of a new gene therapy.
Severe AA Impairs Quality of Life, Study Calls for Holistic Management Strategies
A survey study found a strong association between severe alopecia areata (AA) and significant impairments in quality of life and mental wellbeing, highlighting the need for comprehensive treatment addressing both physical and emotional aspects of the disease.
Ross Margulies Previews 2024 AMCP Annual Conference
Legal expert in health care, partner, and cochair of the health care coverage and reimbursement practice at Foley Hoag LLP, Ross Margulies discusses his excitement and expectations as a featured speaker at the upcoming 2024 AMCP Annual Conference.
Laser-Assisted Drug Delivery Is Effective in Alopecia but Lacks Comparison With Existing Treatments
Studies show that laser-assisted drug delivery (LADD) improves hair growth in patients with alopecia. However, researchers are still looking at the best ways to compare LADD's effectiveness against other methods like microneedling.
Mammography Use Linked to Social Determinants, Revealing Need to Bridge Gaps With Community Support
While mammograms are crucial for early detection of breast cancer and can save lives, social determinants of health and health-related social needs create barriers to access, especially for those with financial hardship, lack of transportation, or social isolation.
Breast Cancer Risk Not Linked to SSRIs; Prolactin Levels Warrant Careful Prescribing
A recent study found a minor link between prolactin levels and the risk of developing estrogen receptor (ER)-positive or ER-negative breast cancers. However, there was no association found between the use of selective serotonin reuptake inhibitors (SSRIs) and breast cancer risk.
Combination Therapies Optimize Hair Regrowth in Pediatric Patients With AA
Corticosteroids are the most common treatment for pediatric patients with alopecia areata (AA), but promising newer options like JAK inhibitors are emerging. This review highlights the importance of personalized treatment plans and maximizing response through combination therapies.
Supporting Breast Cancer Survivors Through Psychosocial Challenges
Breast cancer survivors face a complex landscape of challenges including lingering symptoms, anxieties about the future, identity shifts, and potential social isolation. However, the study identifies personal growth fostered by the experience, further underscoring the critical role of social support and open communication with health care providers in navigating this journey.
Cryoablation Exhibits Advantages as Minimally Invasive Option for Early Breast Cancer
While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires further research for wider adoption.
Light Therapy Clothing Shows Potential for Mild Psoriasis, PMLE, AA Treatment
Red and near-infrared–emitting fabric clothing may improve symptoms of mild psoriasis, polymorphous light eruption (PMLE), and alopecia areata (AA), but further research with larger groups is needed due to limitations in the pilot study design.
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Alopecia Areata Impacts Patient Perception, Quality of Life
Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Deuruxolitinib Demonstrates Efficacy, Tolerability in Patients With Moderate to Severe AA
Posters suggest deuruxolitinib, a medication targeting specific cellular pathways, effectively promotes hair regrowth in patients with moderate to severe alopecia areata (AA) and results in minimal adverse events.
Night Light Pollution Linked to Breast Cancer, Particularly for Asian Populations, ER+ Cases
A large-scale study suggests increased light at night exposure is linked to a higher risk of breast cancer, particularly in Asian populations and women with estrogen receptor-positive tumors (ER+).
Stable Treatment Remained in Early Breast Cancer Diagnosis During Pandemic
A study of patients diagnosed with early breast cancer during the COVID-19 pandemic found that the public health crisis did not produce significant changes in or delays treatment, despite many women presenting with palpable tumors.
Experts Measure AA Severity With Key Factors, Reach Consensus on Treatment Decisions
An expert survey using the eDelphi method pinpointed disease duration, treatment response, and mental health as crucial factors in a new multidimensional tool known as Alopecia Areata Severity and Morbidity Index (ASAMI), underlining the importance of personalized treatments for future research incorporating patient perspectives.
Multigene Assays Advance Genetic Testing in Breast Cancer, Drive Personalized Medicine
Multigene assays allow for patients to receive personalized breast cancer treatment by identifying promising therapeutic targets, which could improve patient clinical outcomes in the long term and help providers better understand tumor biology.